Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities

• Published in: Neuropsychopharmacology (New York, N.Y.) Vol. 42; no. 6; pp. 1201 - 1209
• Main Authors: Li, Meng, Demenescu, Liliana Ramona, Colic, Lejla, Metzger, Coraline Danielle, Heinze, Hans-Jochen, Steiner, Johann, Speck, Oliver, Fejtova, Anna, Salvadore, Giacomo, Walter, Martin
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.05.2017
• Subjects: Adult; Antidepressants; Antidepressive Agents - administration & dosage; Antidepressive Agents - pharmacology; Double-Blind Method; Female; Glutamic Acid - drug effects; Glutamic Acid - metabolism; Glutamine - drug effects; Glutamine - metabolism; Gyrus Cinguli - diagnostic imaging; Gyrus Cinguli - drug effects; Gyrus Cinguli - metabolism; Humans; Ketamine; Ketamine - administration & dosage; Ketamine - pharmacology; Magnetic Resonance Spectroscopy; Male; Medical imaging; Mental depression; Metabolites; Middle Aged; Neurobiology; Neuroimaging; Neurosciences; Original; Psychiatry; Psychotherapy; R&D; Receptors, AMPA - drug effects; Receptors, AMPA - metabolism; Receptors, N-Methyl-D-Aspartate - drug effects; Receptors, N-Methyl-D-Aspartate - metabolism; Research & development; Spectrum analysis; Time Factors; Young Adult; Germany
• ISSN: 0893-133X; 1740-634X
• DOI: 10.1038/npp.2016.184

The anterior cingulate cortex (ACC) has shown decreased glutamate levels in patients with major depressive disorder. Subanesthetic doses of ketamine were repeatedly shown to improve depressive symptoms within 24 h after infusion and this antidepressant effect was attributed to increased α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) throughput. To elucidate ketamine's mechanism of action, we tested whether the clinical time course of the improvement is mirrored by the change of glutamine/glutamate ratio and if such effects show a regional and temporal specificity in two distinct subdivisions of ACC with different AMPA/N-methyl-D-aspartate receptor profiles. In a double-blind, placebo-controlled intravenous infusion study of ketamine, we measured glutamate and glutamine in the pregenual ACC (pgACC) and the anterior midcingulate cortex at 1 and 24 h post infusion with magnetic resonance spectroscopy at 7 T. A significant interaction of time, region, and treatment was found for the glutamine/glutamate ratios (placebo, n=14; ketamine, n=12). Post-hoc analyses revealed that the glutamine/glutamate ratio increased significantly in the ketamine group, compared with placebo, specifically in the pgACC after 24 h. The glutamine/glutamate increase in the pgACC caused by ketamine at 24 h post infusion was reproduced in an enlarged sample (placebo, n=24; ketamine, n=20). Our results support a significant temporal and regional response in glutamine/glutamate ratios to a single subanesthetic dose of ketamine, which mirrors the time course of the antidepressant response and reversal of the molecular deficits in patients and which may be associated with the histoarchitectonical receptor fingerprints of the ACC subregions.